Although several studies show increased global levels of BAG3 in AD [6, 46, 90], the observed increase of global BAG3 in the AD condition can be contributable to the significant increase of BAG3 in the astrocytes (Fig. 4a–d and Fig. 5a–c). This evidence concerns the gene BAG3 and Alzheimer disease.